Search Records

200 datasets found
  • Open Information

    Drug and vaccine authorizations for COVID-19: Overview

    Health Canada scientific reviewers evaluate data to assess the potential benefits and risks of a drug or vaccine. They also review the information that will be provided to health care practitioners and consumers about the product. After the review, we may authorize the drug or vaccine for sale in...
    Organization:
    Health Canada
    Resource Formats:
    • HTML
  • Open Information

    COVID-19 guidance for reporting medical device shortages: Background

    Under the Interim Order, manufacturers and importers must report medical device shortages related to COVID-19 to Health Canada. The devices to which the shortages apply are on the List of Medical Devices — Notification of Shortages (specified medical devices).
    Organization:
    Health Canada
    Resource Formats:
    • HTML
  • Open Information

    Health product advertising incidents related to COVID-19

    COVID-19 is a new disease not previously identified in humans. Health Canada is closely tracking all potential drugs and vaccines in development in Canada and abroad. We are working with companies, academic research centres and investigators to help expedite the development and availability of...
    Organization:
    Health Canada
    Resource Formats:
    • HTML
  • Open Information

    Helping people who use substances during the COVID-19 pandemic

    The COVID-19 pandemic is adding to the ongoing public health crisis related to high rates of opioid overdose and deaths, as well as acute substance use harms. These crises are made worse in communities where there is chronic overcrowding, including a shortage of housing or other shelters.
    Organization:
    Health Canada
    Resource Formats:
    • HTML
  • Open Information

    Joint Statement on Clinical Trial Oversight in Canada

    Health Canada (HC) and the Canadian Institutes of Health Research (CIHR), with the collaboration and participation of the Canadian Association of Research Ethics Boards (CAREB), recognize the urgent need to conduct clinical trials to evaluate the safety and efficacy of a drug, a vaccine or a...
    Organization:
    Health Canada
    Resource Formats:
    • HTML
  • Open Information

    Regulatory considerations for importing or selling face shields: Notice to in...

    Most PPE, including face shields, are Class I medical devices if they are manufactured, sold or represented for use for reducing the risk of or preventing the user from infection. This includes COVID-19. Face shields may be authorized for sale or import into Canada through the following 3...
    Organization:
    Health Canada
    Resource Formats:
    • HTML
  • Open Information

    Safety and performance specifications for respirators during COVID-19: Guidan...

    This document provides guidance for Canadian manufacturers on the minimum technical requirements for facepiece filtering respirators (FFR). Health Canada has also published a guidance document to assist manufacturers in preparing applications submitted under the IO. This guidance document should...
    Organization:
    Health Canada
    Resource Formats:
    • HTML
  • Open Information

    Interim guidance: Care of residents in long term care homes during the COVID-...

    This document provides care guidance specific to the COVID-19 pandemic in Canadian homes/facilities where older adults require continuous supervised care, including professional health services, personal care and other services such as meals, laundry and housekeeping.
    Organization:
    Public Health Agency of Canada
    Resource Formats:
    • HTML
You can also access this registry using the API (see API Docs).